Cresset Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.11M | Sell |
36,076
-5,725
| -14% | -$502K | 0.01% | 537 |
|
|
2026
Q1 | $3.79M | Buy |
41,801
+1,541
| +4% | +$141K | 0.02% | 423 |
|
|
2025
Q4 | $3.63M | Buy |
40,260
+17
| +0% | +$1.61K | 0.02% | 430 |
|
|
2025
Q3 | $3.97M | Buy |
40,243
+10
| +0% | +$991 | 0.02% | 391 |
|
|
2025
Q2 | $3.68M | Sell |
40,233
-2,986
| -7% | -$289K | 0.02% | 380 |
|
|
2025
Q1 | $4.9M | Buy |
43,219
+6,011
| +16% | +$643K | 0.02% | 351 |
|
|
2024
Q4 | $3.94M | Sell |
37,208
-8,477
| -19% | -$910K | 0.02% | 397 |
|
|
2024
Q3 | $4.94M | Sell |
45,685
-218
| -0.5% | -$23.8K | 0.02% | 457 |
|
|
2024
Q2 | $4.99M | Sell |
45,903
-1,337
| -3% | -$158K | 0.02% | 427 |
|
|
2024
Q1 | $6.25M | Buy |
47,240
+5,700
| +14% | +$712K | 0.03% | 340 |
|
|
2023
Q4 | $5.07M | Sell |
41,540
-6,029
| -13% | -$673K | 0.03% | 336 |
|
|
2023
Q3 | $5.35M | Buy |
47,569
+2,714
| +6% | +$345K | 0.02% | 319 |
|
|
2023
Q2 | $6.54M | Buy |
44,855
+10,727
| +31% | +$1.46M | 0.01% | 352 |
|
|
2023
Q1 | $4.41M | Buy |
34,128
+32,414
| +1,891% | +$4.07M | 0.09% | 141 |
|
|
2022
Q4 | $211K | Sell |
1,714
-288
| -14% | -$33.4K | ﹤0.01% | 622 |
|
|
2022
Q3 | $210K | Buy |
2,002
+8
| +0.4% | +$878 | ﹤0.01% | 782 |
|
|
2022
Q2 | $209K | Sell |
1,994
-1,184
| -37% | -$140K | ﹤0.01% | 828 |
|
|
2022
Q1 | $408K | Sell |
3,178
-27
| -0.8% | -$3.25K | ﹤0.01% | 671 |
|
|
2021
Q4 | $396K | Sell |
3,205
-1,292
| -29% | -$169K | ﹤0.01% | 777 |
|
|
2021
Q3 | $640K | Buy |
4,497
+475
| +12% | +$69.9K | 0.01% | 534 |
|
|
2021
Q2 | $629K | Buy |
4,022
+253
| +7% | +$41K | 0.01% | 489 |
|
|
2021
Q1 | $586K | Buy |
3,769
+496
| +15% | +$76.8K | 0.01% | 435 |
|
|
2020
Q4 | $491K | Sell |
3,273
-351
| -10% | -$49.6K | 0.01% | 400 |
|
|
2020
Q3 | $479K | Buy |
3,624
+229
| +7% | +$29.9K | 0.01% | 382 |
|
|
2020
Q2 | $394K | Buy |
3,395
+73
| +2% | +$8.41K | 0.01% | 383 |
|
|
2020
Q1 | $327K | Buy |
3,322
+1,009
| +44% | +$132K | 0.01% | 366 |
|
|
2019
Q4 | $336K | Buy |
2,313
+547
| +31% | +$75.5K | 0.01% | 392 |
|
|
2019
Q3 | $235K | Buy |
1,766
+18
| +1% | +$2.33K | 0.01% | 453 |
|
|
2019
Q2 | $200K | Buy |
1,748
+1,371
| +364% | +$161K | 0.01% | 450 |
|
|
2019
Q1 | $47K | Buy |
377
+166
| +79% | +$18.9K | ﹤0.01% | 809 |
|
|
2018
Q4 | $21K | Buy |
+211
| New | +$23.7K | ﹤0.01% | 704 |
|
Other funds holding ZBH
Cresset Asset Management's ZBH Position: Q2 2026 in Review
Cresset Asset Management reduced its Zimmer Biomet (ZBH) stake by 14% in Q2 2026, selling an estimated $502K and leaving 36,076 shares worth $3.11M. The position accounts for 0.01% of the portfolio, ranked #537.
Cresset Asset Management first reported a position in ZBH in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.54M in Q2 2023. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Cresset Asset Management held 36,076 shares of Zimmer Biomet worth $3.11M as of Q2 2026.
- Cresset Asset Management sold 5,725 Zimmer Biomet shares in Q2 2026, an estimated $502K.
- Zimmer Biomet made up 0.01% of Cresset Asset Management's portfolio in Q2 2026, its #537 holding.
- Cresset Asset Management first reported a position in Zimmer Biomet in Q4 2018 and has held it in 31 quarters since.
- Cresset Asset Management's Zimmer Biomet position peaked at $6.54M in Q2 2023.
- 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.